The authors thank Sophie Patrier and Marianne Par&#233;sy for sharing the original flow cytometry protocol, and Promega and Qiagen for providing supplies and reagents. This work was supported by the R&#233;seau Qu&#233;b&#233;cois en Reproduction and the Canadian Institute for Health Research (MOP-130364) to R.S.

<ol>
	<li>Szulman, A. E., Surti, U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+syndromes+of+hydatidiform+mole.+II.+Morphologic+evolution+of+the+complete+and+partial+mole.">The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole.</a> American Journal of Obstetrics &amp; Gynecology. 132 (1), 20-27 (1978).</li><li>Fukunaga, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Interobserver+and+intraobserver+variability+in+the+diagnosis+of+hydatidiform+mole.">Interobserver and intraobserver variability in the diagnosis of hydatidiform mole.</a> The American Journal of Surgical Pathology. 29 (7), 942-947 (2005).</li><li>Gupta, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Diagnostic+reproducibility+of+hydatidiform+moles:+ancillary+techniques+(p57+immunohistochemistry+and+molecular+genotyping)+improve+morphologic+diagnosis+for+both+recently+trained+and+experienced+gynecologic+pathologists.">Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.</a> The American Journal of Surgical Pathology. 36 (12), 1747-1760 (2012).</li><li>Howat, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Can+histopathologists+reliably+diagnose+molar+pregnancy?.">Can histopathologists reliably diagnose molar pregnancy?.</a> Journal of Clinical Pathology. 46 (7), 599-602 (1993).</li><li>Banet, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Characteristics+of+hydatidiform+moles:+analysis+of+a+prospective+series+with+p57+immunohistochemistry+and+molecular+genotyping.">Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.</a> Modern Pathology. 27 (2), 238-254 (2014).</li><li>Lipata, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Precise+DNA+genotyping+diagnosis+of+hydatidiform+mole.">Precise DNA genotyping diagnosis of hydatidiform mole.</a> Obstetrics &amp; Gynecology. 115 (4), 784-794 (2010).</li><li>Buza, N., Hui, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Partial+hydatidiform+mole:+histologic+parameters+in+correlation+with+DNA+genotyping.">Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping.</a> International Journal of Gynecologic Pathology. 32 (3), 307-315 (2013).</li><li>Fisher, R. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Frequency+of+heterozygous+complete+hydatidiform+moles,+estimated+by+locus-specific+minisatellite+and+Y+chromosome-specific+probes.">Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes.</a> Human Genetics. 82 (3), 259-263 (1989).</li><li>Murdoch, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mutations+in+NALP7+cause+recurrent+hydatidiform+moles+and+reproductive+wastage+in+humans.">Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans.</a> Nature Genetics. 38 (3), 300-302 (2006).</li><li>Parry, D. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mutations+causing+familial+biparental+hydatidiform+mole+implicate+c6orf221+as+a+possible+regulator+of+genomic+imprinting+in+the+human+oocyte.">Mutations causing familial biparental hydatidiform mole implicate c6orf221 as a possible regulator of genomic imprinting in the human oocyte.</a> American Journal of Human Genetics. 89 (3), 451-458 (2011).</li><li>Nguyen, N. M., Slim, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Genetics+and+Epigenetics+of+Recurrent+Hydatidiform+Moles:+Basic+Science+and+Genetic+Counselling.">Genetics and Epigenetics of Recurrent Hydatidiform Moles: Basic Science and Genetic Counselling.</a> Current Obstetrics and Gynecology Reports. 3, 55-64 (2014).</li><li>Sebire, N. J., Savage, P. M., Seckl, M. J., Fisher, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Histopathological+features+of+biparental+complete+hydatidiform+moles+in+women+with+NLRP7+mutations.">Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations.</a> Placenta. 34 (1), 50-56 (2013).</li><li>Nguyen, N. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comprehensive+genotype-phenotype+correlations+between+NLRP7+mutations+and+the+balance+between+embryonic+tissue+differentiation+and+trophoblastic+proliferation.">Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation.</a> Journal of Medical Genetics. 51 (9), 623-634 (2014).</li><li>Brown, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Recurrent+pregnancy+loss+in+a+woman+with+NLRP7+mutation:+not+all+molar+pregnancies+can+be+easily+classified+as+either+"partial"+or+"complete"+hydatidiform+moles.">Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either "partial" or "complete" hydatidiform moles.</a> International Journal of Gynecologic Pathology. 32 (4), 399-405 (2013).</li><li>Colgan, T. J., Chang, M. C., Nanji, S., Kolomietz, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Reappraisal+of+the+Incidence+of+Placental+Hydatidiform+Mole+Using+Selective+Molecular+Genotyping.">A Reappraisal of the Incidence of Placental Hydatidiform Mole Using Selective Molecular Genotyping.</a> The International Journal of Gynecological Cancer. 26 (7), 1345-1350 (2016).</li><li>Murphy, K. M., McConnell, T. G., Hafez, M. J., Vang, R., Ronnett, B. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+genotyping+of+hydatidiform+moles:+analytic+validation+of+a+multiplex+short+tandem+repeat+assay.">Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay.</a> The Journal of Molecular Diagnostics. 11 (6), 598-605 (2009).</li></ol>

The authors have nothing to disclose.

HM are abnormal human pregnancies with heterogeneous etiologies and have different histological and genotypic types, which makes their accurate classification and diagnosis challenging. Histopathological morphological evaluation was often proven inaccurate and is therefore unreliable on its own to classify HM into CHM and PHM and distinguish them from non-molar miscarriages. Therefore, an accurate diagnosis of HM requires the use of other methods such as multiplex microsatellite DNA genotyping, ploidy analysis by flow cy...

A hydatidiform mole (HM) is an abnormal human pregnancy characterized by abnormal embryonic development, hyperproliferation of the trophoblast, and hydropic degeneration of chorionic villi (CV). Historically, HM used to be divided into two types, complete HM (CHM) and partial HM (PHM) based only on morphological evaluation1. However, it has been shown that morphological evaluation alone is not sufficient to classify HM into the two subtypes (CHM and PHM) and distinguish them from non-molar miscarriages2,3,4.
Because CHM and PHM have different propensities to malignancies, it is therefore important to accurately determine the genotypic type of HM to provide appropriate follow-up and management to the patients. Consequently, in the past decades, several methodologies have been developed and evolved for the purpose of identifying the parental contribution to the molar tissues and reaching a correct classification of HM. These include karyotype analysis, chromosomal banding polymorphism, human leukocyte antigen (HLA) serological typing, restriction fragment length polymorphism, variable number of tandem repeats, microsatellite genotyping, flow cytometry, and p57KIP2 immunohistochemistry. This has allowed accurate subdivision of HM conceptions based on the parental contribution to their genomes, as follows: CHM, which are diploid androgenetic monospermic or diploid androgenetic dispermic, and PHM, which are triploid, dispermic in 99% and monospermic in 1% of the cases5,6,7,8. Furthermore, there is another genotypic type of HM that emerged in the past two decades, which is diploid biparental. The latter is mostly recurrent and may affect a single family member (simplex cases) or at least two family members (familial cases). These diploid biparental moles are mostly caused by recessive mutations in NLRP7 or KHDC3L in the patients9,10,11,12. Diploid biparental HM in patients with recessive mutations in NLRP7 may be diagnosed as CHM or PHM by morphological analysis and this appears to be associated with the severity of the mutations in the patients13,14. In addition to the classification of HM according to their genotypes, the introduction and use of several genotyping methods allowed the distinction of the various molar entities from non-molar miscarriages, such as aneuploid diploid biparental conceptions and other types of conceptions5,15. Such conceptions may have some trophoblast proliferation and abnormal villous morphology that mimic, to some extent, some morphological features of HM.
The purpose of this article is to provide detailed protocols for multiplex genotyping and flow cytometry of formalin-fixed paraffin-embedded (FFPE) tissues, and comprehensive analyses of the results of these methods and their integration with other methods for correct and conclusive diagnosis of molar tissues.

<table><tbody><tr><td>BD FACS Canto II</td><td>BD BioSciences</td><td>338960</td><td></td></tr><tr><td>Capillary electrophoresis instrument: Genomes Applied Biosystems 3730xl DNA Analyzer</td><td>Applied biosystems</td><td>313001R</td><td>Service offered by the Centre for Applied Genomics&lt;br/&gt;(http://www.tcag.ca)</td></tr><tr><td>Citric acid</td><td>Sigma</td><td>251275</td><td></td></tr><tr><td>Cytoseal 60, histopathology mounting medium</td><td>Fisher</td><td>23244257</td><td></td></tr><tr><td>Eosin Y stock solution (1%)</td><td>Fisher</td><td>SE23-500D</td><td></td></tr><tr><td>FCSalyzer - flow cytometry analysis software</td><td>SourceForge</td><td>-</td><td>https://sourceforge.net/projects/fcsalyzer/</td></tr><tr><td>FFPE Qiagen kit</td><td>Qiagen</td><td>80234</td><td></td></tr><tr><td>Forceps</td><td>Fine Science Tools</td><td>11295-51</td><td>For sectioning and for the cleaning process</td></tr><tr><td>Glacial Acetic Acid (Concentrated)</td><td>Sigma</td><td>A6283-500mL</td><td></td></tr><tr><td>Glass coverslips: Cover Glass</td><td>Fisher</td><td>12-541a</td><td></td></tr><tr><td>Hematoxylin</td><td>Fisher</td><td>CS401-1D</td><td></td></tr><tr><td>Highly deionized formamide: Hi-Di Formamide</td><td>Thermofisher</td><td>4311320</td><td></td></tr><tr><td>IHC platform: Benchmark Ultra</td><td>Roche</td><td>-</td><td></td></tr><tr><td>Kimwipes</td><td>Ultident</td><td>30-34120</td><td></td></tr><tr><td>Microtome</td><td>Leica</td><td>RM2135</td><td></td></tr><tr><td>Microtome blades</td><td>Fisher</td><td>12-634-1C</td><td></td></tr><tr><td>Nitex filtering mesh, 48 &amp;mu;m</td><td>Filmar</td><td>74011</td><td>http://www.filmar.qc.ca/index.php?filet=produits&amp;amp;id=51&amp;amp;lang=en ; any other filter is suitable, but this is an inexpensive and effective option from a non-research company</td></tr><tr><td>p57 antibody</td><td>Cell Marque</td><td>457M</td><td></td></tr><tr><td>Pasteur pipette</td><td>VWR</td><td>53499-632</td><td></td></tr><tr><td>PCR machine</td><td>Perkin Elmer, Applied Biosystems</td><td>GeneAmp PCR System 9700</td><td></td></tr><tr><td>PeakScanner 1.0</td><td>Applied Biosystems</td><td>4381867</td><td>Software for genotyping analysis.</td></tr><tr><td>Pepsin from porcine gastric mucosa</td><td>Sigma</td><td>P7012</td><td></td></tr><tr><td>Polystyrene round-bottom tubes</td><td>BD Falcon</td><td>352058</td><td></td></tr><tr><td>Positively charged slides: Superfrost Plus 25x75mm</td><td>Fisher</td><td>1255015</td><td></td></tr><tr><td>PowerPlex 16 HS System</td><td>Promega Corporation</td><td>DC2102</td><td></td></tr><tr><td>Propidium Iodide</td><td>Sigma</td><td>P4864</td><td></td></tr><tr><td>Ribonuclease A from bovine pancreas</td><td>Sigma</td><td>R4875</td><td></td></tr><tr><td>Separation matrix: POP-7 Polymer</td><td>Thermofisher</td><td>4352759</td><td></td></tr><tr><td>UltraPure Agarose</td><td>Fisher</td><td>16500-500</td><td></td></tr><tr><td>Xylene</td><td>Fisher</td><td>X3P1GAL</td><td></td></tr></tbody></table>

microsatellite dna genotyping and flow cytometry ploidy analyses of formalin-fixed paraffin-embedded hydatidiform molar tissues

Hydatidiform mole (HM) is an abnormal human pregnancy characterized by excessive trophoblastic proliferation and abnormal embryonic development. There are two types of HM based on microscopic morphological evaluation, complete HM (CHM) and partial HM (PHM). These can be further subdivided based on the parental contribution to the molar genomes. Such characterization of HM, by morphology and genotype analyses, is crucial for patient management and for the fundamental understanding of this intriguing pathology. It is well documented that morphological analysis of HM is subject to wide interobserver variability and is not sufficient on its own to accurately classify HM into CHM and PHM and distinguish them from hydropic non-molar abortions. Genotyping analysis is mostly performed on DNA and tissues from formalin-fixed paraffin-embedded (FFPE) products of conception, which have less than optimal quality and may consequently lead to wrong conclusions. In this article, detailed protocols for multiplex genotyping and flow cytometry analyses of FFPE molar tissues are provided, along with the interpretation of the results of these methods, their troubleshooting, and integration with the morphological evaluation, p57KIP2 immunohistochemistry, and fluorescence in situ hybridization (FISH) to reach a correct and robust diagnosis. Here, the authors share the methods and lessons learned in the past 10 years from the analysis of approximately 400 products of conception.

The complexity of molar tissues and the fact that they may have various genotypes necessitates stringent analysis and the use of several methods such as morphological evaluation, p57 immunohistochemistry, microsatellite genotyping, flow cytometry, and FISH. For example, one patient (1790) was referred with two PHM that were found to be triploid by microarray analysis of the POCs only. The patient was therefore diagnosed with recurrent PHM. Microsatellite genotyping of her two &#34;PHM&#34...

Watch this Scientific Journal Video about Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues at JoVE.com

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

Hydatidiform moles are abnormal human pregnancies with heterogeneous aetiologies that can be classified according to their morphological features and parental contribution to the molar genomes. Here, protocols of multiplex microsatellite DNA genotyping and flow cytometry of formalin-fixed paraffin-embedded molar tissues are described in detail, together with results&#8217; interpretation and integration.

Hydatidiform mole (HM) is an abnormal human pregnancy characterized by excessive trophoblastic proliferation and abnormal embryonic development. There are ...

microsatellite-dna-genotyping-flow-cytometry-ploidy-analyses-formalin

Research

JoVE Journal

Genetics

9.1K Views.  McGill University. Het belangrijkste voordeel van ons genotyperingprotocol is dat het besmetting met moeder-DNA minimaliseert, wat de belangrijkste uitdaging is bij het genotyperen van formeel vaste, paraffine-ingebedde molaire weefsels. Flow cytometrie is een snelle en goedkope methode die sterk vergemakkelijkt de diagnose van hydatidiform moedervlekken. Voor elke formaline-vaste paraffine-embedded, of FFPE, product van de conceptie, bereiden een vier-micron dikke hematoxylin en eosine vlek sectie zoals beschr...

Video: Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

FISH for Pre-implantation Genetic Diagnosis 

Pre-implantation genetic diagnosis (PGD) is an established alternative to pre-natal diagnosis, and involves selecting pre-implantation embryos from a cohort generated by assisted reproduction technology (ART). This selection may be required because of familial monogenic disease (e.g. cystic fibrosis), or because one partner carries a chromosome rearrangement (e.g. a two-way reciprocal translocation). PGD is available for couples who have had previous affected children, and/or in the case of chromosome rearrangements, recurrent miscarriages, or infertility. Oocytes aspirated following ovarian stimulation are fertilized by in vitro immersion in semen (IVF) or by intracytoplasmic injection of an individual spermatozoon (ICSI). Pre-implantation cleavage-stage embryos are biopsied, usually by the removal of a single cell on day 3 post-fertilization, and the biopsied cell is tested to establish the genetic status of the embryo. Fluorescence in situ hybridization (FISH) on the fixed nuclei of biopsied cells with target-specific DNA probes is the technique of choice to detect chromosome imbalance associated with chromosome rearrangements, and to select female embryos in families with X-linked disease for which there is no mutation-specific test. FISH has also been used to screen embryos for spontaneous chromosome aneuploidy (also known as PGS or PGD-AS) in order to try and improve the efficiency of assisted reproduction; however, the predictive value of this test using the spreading and FISH technique described here is likely to be unacceptably low in most people's hands and it is not recommended for routine clinical use. We describe the selection of suitable probes for single-cell FISH, spreading techniques for blastomere nuclei, and in situ hybridization and signal scoring, applied to PGD in a clinical setting.

FISH for Pre-implantation Genetic Diagnosis

This article describes the selection of suitable probes for single-cell FISH, spreading techniques for blastomere nuclei, and in situ hybridization and signal scoring, applied to pre-implantation genetic diagnosis (PGD) in a clinical setting.

Pre-implantation genetic diagnosis (PGD) is an established alternative to pre-natal diagnosis, and involves selecting pre-implantation embryos from a ...

Medicine

Flow Cytometry Purification of Mouse Meiotic Cells

The heterogeneous nature of cell types in the testis and the absence of meiotic cell culture models have been significant hurdles to the study of the unique differentiation programs that are manifest during meiosis. Two principal methods have been developed to purify, to varying degrees, various meiotic fractions from both adult and immature animals: elutriation or Staput (sedimentation) using BSA and/or percoll gradients. Both of these methods rely on cell size and density to separate meiotic cells1-5. Overall, except for few cell populations6, these protocols fail to yield sufficient purity of the numerous meiotic cell populations that are necessary for detailed molecular analyses. Moreover, with such methods usually one type of meiotic cells can be purified at a given time, which adds an extra level of complexity regarding the reproducibility and homogeneity when comparing meiotic cell samples.
Here, we describe a refined method that allows one to easily visualize, identify, and purify meiotic cells, from germ cells to round spermatids, using FACS combined with Hoechst 33342 staining7,8. This method provides an overall snapshot of the entire meiotic process and allows one to highly purify viable cells from most stage of meiosis. These purified cells can then be analyzed in detail for molecular changes that accompany progression through meiosis, for example changes in gene expression9,10and the dynamics of nucleosome occupancy at hotspots of meiotic recombination11.

An efficient method to obtain highly purified viable meiotic fractions from mouse testis is described, which combines a refined cell dissociation protocol with fluorescent activated cell sorting (FACS). This method takes advantage of differences in the DNA content and nuclear density of discrete meiotic fractions.

The heterogeneous nature of cell types in the testis and the absence of meiotic cell culture models have been significant hurdles to the study of the ...

Biology

Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics

A multiplexed droplet PCR (mdPCR) workflow and detailed protocol for determining epigenetic-based white blood cell (WBC) differential count is described, along with a thermoplastic elastomer (TPE) microfluidic droplet generation device. Epigenetic markers are used for WBC&#160;subtyping which is of important prognostic value in different diseases. This is achieved through the quantification of DNA methylation patterns of specific CG-rich regions in the genome (CpG loci). In this paper, bisulfite-treated DNA from peripheral blood mononuclear cells (PBMCs) is encapsulated in droplets with mdPCR reagents including primers and hydrolysis fluorescent probes specific for CpG loci that correlate with WBC sub-populations. The multiplex approach allows for the interrogation of many CpG loci without the need for separate mdPCR reactions, enabling more accurate parametric determination of WBC sub-populations using epigenetic analysis of methylation sites. This precise quantification can be extended to different applications and highlights the benefits for clinical diagnosis and subsequent prognosis.

Epigenetic markers are used for white blood cell (WBC) subtyping through the quantification of DNA methylation patterns. This protocol presents a multiplex droplet polymerase chain reaction (mdPCR) method using a thermoplastic elastomer (TPE)-based microfluidic device for droplet generation allowing for precise and multiplex methylation-specific target quantification of WBC differential counts.

A multiplexed droplet PCR (mdPCR) workflow and detailed protocol for determining epigenetic-based white blood cell (WBC) differential count is described, ...

Bioengineering

Single Oocyte Bisulfite Mutagenesis

Epigenetics encompasses all heritable and reversible modifications to chromatin that alter gene accessibility, and thus are the primary mechanisms for regulating gene transcription1. DNA methylation is an epigenetic modification that acts predominantly as a repressive mark. Through the covalent addition of a methyl group onto cytosines in CpG dinucleotides, it can recruit additional repressive proteins and histone modifications to initiate processes involved in condensing chromatin and silencing genes2. DNA methylation is essential for normal development as it plays a critical role in developmental programming, cell differentiation, repression of retroviral elements, X-chromosome inactivation and genomic imprinting.
One of the most powerful methods for DNA methylation analysis is bisulfite mutagenesis. Sodium bisulfite is a DNA mutagen that deaminates cytosines into uracils. Following PCR amplification and sequencing, these conversion events are detected as thymines. Methylated cytosines are protected from deamination and thus remain as cytosines, enabling identification of DNA methylation at the individual nucleotide level3. Development of the bisulfite mutagenesis assay has advanced from those originally reported4-6 towards ones that are more sensitive and reproducible7. One key advancement was embedding smaller amounts of DNA in an agarose bead, thereby protecting DNA from the harsh bisulfite treatment8. This enabled methylation analysis to be performed on pools of oocytes and blastocyst-stage embryos9. The most sophisticated bisulfite mutagenesis protocol to date is for individual blastocyst-stage embryos10. However, since blastocysts have on average 64 cells (containing 120-720 pg of genomic DNA), this method is not efficacious for methylation studies on individual oocytes or cleavage-stage embryos.
Taking clues from agarose embedding of minute DNA amounts including oocytes11, here we present a method whereby oocytes are directly embedded in an agarose and lysis solution bead immediately following retrieval and removal of the zona pellucida from the oocyte. This enables us to bypass the two main challenges of single oocyte bisulfite mutagenesis: protecting a minute amount of DNA from degradation, and subsequent loss during the numerous protocol steps. Importantly, as data are obtained from single oocytes, the issue of PCR bias within pools is eliminated. Furthermore, inadvertent cumulus cell contamination is detectable by this method since any sample with more than one methylation pattern may be excluded from analysis12. This protocol provides an improved method for successful and reproducible analyses of DNA methylation at the single-cell level and is ideally suited for individual oocytes as well as cleavage-stage embryos.

Bisulfite mutagenesis is the gold standard for analyzing DNA methylation. Our modified protocol allows for DNA methylation analysis at the single-cell level and was specifically designed for individual oocytes. It can also be used for cleavage-stage embryos.

Epigenetics encompasses all heritable and reversible modifications to chromatin that alter gene accessibility, and thus are the primary mechanisms for ...

qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue

It is crucial to identify cytomegalovirus (CMV) infection in the gastrointestinal (GI) tract of immunosuppressed patients, given their greater risk for developing severe infection. Many laboratory methods for the detection of CMV infection have been developed, including serology, viral culture, and molecular methods. Often, these methods reflect systemic involvement with CMV and do not specifically identify local tissue involvement. Therefore, detection of CMV infection in the GI tract is frequently done by traditional histology of biopsy tissue. Hematoxylin and eosin (H&#38;E) staining in conjunction with immunohistochemistry (IHC) have remained the mainstays of examining these biopsies. H&#38;E and IHC sometimes result in atypical (equivocal) staining patterns, making interpretation difficult. It was shown that quantitative polymerase chain reaction (qPCR) for CMV can successfully be performed on formalin-fixed, paraffin-embedded (FFPE) biopsy tissue for very high sensitivity and specificity. The goal of this protocol is to demonstrate how to perform qPCR testing for the detection of CMV in FFPE biopsy tissue in a clinical laboratory setting. This method is likely to be of great benefit for patients in cases of equivocal staining for CMV in GI biopsies.

This protocol describes qPCR detection of cytomegalovirus in formalin-fixed, paraffin-embedded biopsy tissue, which is rapid, sensitive, specific, and useful for interpreting equivocal hematoxylin and eosin or immunohistochemical staining patterns.

It is crucial to identify cytomegalovirus (CMV) infection in the gastrointestinal (GI) tract of immunosuppressed patients, given their greater risk for ...

Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction

Formalin-fixed paraffin embedded tissue (FFPET) represents a valuable, well-annotated substrate for molecular investigations. The utility of FFPET in molecular analysis is complicated both by heterogeneous tissue composition and low yields when extracting nucleic acids. A literature search revealed a paucity of protocols addressing these issues, and none that showed a validated method for simultaneous extraction of RNA and DNA from regions of interest in FFPET. This method addresses both issues. Tissue specificity was achieved by mapping cancer areas of interest on microscope slides and transferring annotations onto FFPET blocks. Tissue cores were harvested from areas of interest using 0.6 mm microarray punches. Nucleic acid extraction was performed using a commercial FFPET extraction system, with modifications to homogenization, deparaffinization, and Proteinase K digestion steps to improve tissue digestion and increase nucleic acid yields. The modified protocol yields sufficient quantity and quality of nucleic acids for use in a number of downstream analyses, including a multi-analyte gene expression platform, as well as reverse transcriptase coupled real time PCR analysis of mRNA expression, and methylation-specific PCR (MSP) analysis of DNA methylation.

This modified extraction protocol improves RNA and DNA yields from more precisely targeted regions of interest in histopathologic tissue blocks.

Formalin-fixed paraffin embedded tissue (FFPET) represents a valuable, well-annotated substrate for molecular investigations. The utility of FFPET in ...

Flow Cytometric Analysis of Biomarkers for Detecting Human Sperm Functional Defects

The conventional semen parameter analysis is widely used to assess male fertility. However, studies have found that ~15% of infertile patients show no abnormalities in conventional semen parameters. Additional technologies are needed to explain the idiopathic infertility and detect subtle sperm defects. Currently, biomarkers of sperm function, including sperm apoptosis, mitochondrial membrane potential (MMP), and DNA damage, reveal sperm physiology at the molecular level and are capable of predicting male fertility.
With flow cytometry (FCM) techniques, each of these markers can be rapidly, accurately, and precisely measured in human semen samples, but time costs substantially increase and results could be obstructed if all the biomarkers need to be tested with a single cytometer. In this protocol, after collection and immediate incubation at 37 &#176;C for liquefication, semen samples were further analyzed for sperm apoptosis using Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) staining. The MMP was labeled with 5,5&#8242;,6,6&#8242;-tetrachloro-1,1&#8242;,3,3&#8242;-tetraethyl-benzimidazolylcarbocyanine iodide (JC-1) probe, and DNA damage was assessed using the sperm chromatin structure assay (SCSA) with acridine orange (AO) staining. Thus, flow cytometric analysis of sperm function markers can be a practical and reliable toolkit for the diagnosis of infertility and evaluation of sperm function at both bench and bed.

The present protocol provides a practical solution that allows for the measurement of apoptosis, mitochondrial membrane potential, and DNA damage in human sperm with a single cytometer.

The conventional semen parameter analysis is widely used to assess male fertility. However, studies have found that ~15% of infertile patients show no ...

Measuring Single-Cell Mitochondrial DNA Copy Number and Heteroplasmy Using Digital Droplet Polymerase Chain Reaction

The mammalian mitochondrial (mt)DNA is a small, circular, double-stranded, intra-mitochondrial DNA molecule, encoding 13 subunits of the electron transport chain. Unlike the diploid nuclear genome, most cells contain many more copies of mtDNA, ranging from less than 100 to over 200,000 copies depending on cell type. MtDNA copy number is increasingly used as a biomarker for a number of age-related degenerative conditions and diseases, and thus, accurate measurement of the mtDNA copy number is becoming a key tool in both research and diagnostic settings. Mutations in the mtDNA, often occurring as single nucleotide polymorphisms (SNPs) or deletions, can either exist in all copies of the mtDNA within the cell (termed homoplasmy) or as a mixture of mutated and WT mtDNA copies (termed heteroplasmy). Heteroplasmic mtDNA mutations are a major cause of clinical mitochondrial pathology, either in rare diseases or in a growing number of common late-onset diseases such as Parkinson's disease. Determining the level of heteroplasmy present in cells is a critical step in the diagnosis of rare mitochondrial diseases and in research aimed at understanding common late-onset disorders where mitochondria may play a role. MtDNA copy number and heteroplasmy have traditionally been measured by quantitative (q)PCR-based assays or deep sequencing. However, the recent introduction of ddPCR technology has provided an alternative method for measuring both parameters. It offers several advantages over existing methods, including the ability to measure absolute mtDNA copy number and sufficient sensitivity to make accurate measurements from single cells even at low copy numbers. Presented here is a detailed protocol describing the measurement of mtDNA copy number in single cells using ddPCR, referred to as droplet generation PCR henceforth, with the option for simultaneous measurement of heteroplasmy in cells with mtDNA deletions. The possibility of expanding this method to measure heteroplasmy in cells with mtDNA SNPs is also discussed.

Here we present a protocol for measuring absolute mitochondrial (mt)DNA copy number and mtDNA deletion heteroplasmy levels in single cells.

The mammalian mitochondrial (mt)DNA is a small, circular, double-stranded, intra-mitochondrial DNA molecule, encoding 13 subunits of the electron ...

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Mutations in the mitochondrial genome (mtDNA) have been associated with maternally inherited genetic diseases. However, interest in mtDNA polymorphisms has increased in recent years due to the recently developed ability to produce models by mtDNA mutagenesis and a new appreciation of the association between mitochondrial genetic aberrations and common age-related diseases such as cancer, diabetes, and dementia. Pyrosequencing is a sequencing-by-synthesis technique that is widely employed across the mitochondrial field for routine genotyping experiments. Its relative affordability when compared to massive parallel sequencing methods and ease of implementation make it an invaluable technique in the field of mitochondrial genetics, allowing for the rapid quantification of heteroplasmy with increased flexibility. Despite the practicality of this method, its implementation as a means of mtDNA genotyping requires the observation of certain guidelines, specifically to avoid certain biases of biological or technical origin. This protocol outlines the necessary steps and precautions in designing and implementing pyrosequencing assays for use in the context of heteroplasmy measurement.

Pyrosequencing assays enable the robust and rapid genotyping of mitochondrial DNA single nucleotide polymorphisms in heteroplasmic cells or tissues.

Mutations in the mitochondrial genome (mtDNA) have been associated with maternally inherited genetic diseases. However, interest in mtDNA polymorphisms ...

Capturing Oral Submucous Fibrosis Tissue Samples for Spatial-Omics Analysis

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection

Oral submucous fibrosis (OSF) is a common type of potentially malignant disorder in the oral cavity. The atrophy of epithelium and fibrosis of the lamina propria and the submucosa are often found on histopathological slides. Epithelial dysplasia, epithelial atrophy, and senescent fibroblasts have been proposed to be associated with the malignant transformation of OSF. However, because of the heterogeneity of potentially malignant oral disorders and oral squamous cell carcinoma, it is difficult to identify the specific molecular mechanisms of malignant transformation in OSF. Here, we present a method to obtain a small number of epithelial or mesenchymal cells carrying morphological data and spatial information by laser capture microdissection on formalin-fixed paraffin-embedded tissue slides. Using a microscope, we can precisely capture microscale (~500 cells) dysplastic or atrophic epithelial tissue and fibrotic subepithelial tissue. The extracted cells can be evaluated by genome or transcriptome sequencing to acquire genomic and transcriptomic data with morphological and spatial information. This approach removes the heterogeneity of bulk OSF tissue sequencing and the interference caused by cells in non-lesioned areas, allowing for precise spatial-omics analysis of OSF tissue.

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies 

Laser capture microdissection of oral submucous fibrosis tissues allows for precise extraction of cells from histological regions of interest for the analysis of multi-omics data with morphological and spatial information.

Oral submucous fibrosis (OSF) is a common type of potentially malignant disorder in the oral cavity. The atrophy of epithelium and fibrosis of the lamina ...

Microsatellite DNA Genotyping and Flow Cytometry Ploidy Analyses of Formalin-fixed Paraffin-embedded Hydatidiform Molar Tissues

Samenvatting

Meer video's verkennen